HOME TECHNOLOGY COMPANY PROFILE SERVICES PIPELINE NEWS CONTACT US SEARCH Innovative delivery technology Silica-based drug delivery for controlled release of small molecules and biopharmaceuticals. READ MORE 1 2 3 4 TECHNOLOGY APPLICABLE TO A WIDE RANGE OF DRUG DELIVERY NEEDS DelSiTech is the leading technology specialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parenteral and local administration of drug products. VIRAL VECTORS AND VACCINES SMALL MOLECULES PROTEINS AND MACROMOLECULES OUR PARTNERS DelSiTech currently holds technology licensing agreements with Bayer Pharma AG and Solani Therapeutics Ltd and evaluation agreements with several pharma, animal health and biotech companies. UPCOMING EVENTS DelSiTech to present in the 6th annual Partnership Opportunities in Drug Delivery conference in Boston, MA, in October 27-28, 2016 27-28 October Boston, MA, USA NEWS DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology 29 SEP DelSiTech CEO Lasse Leino interviewed for the benefits of silica based drug delivery on PharmaTelevison 23 JUN ALL NEWS Contact Itäinen Pitkäkatu 4 B 20520 TURKU, FINLAND Tel. +358 2 2510 110 Fax. +358 2 2510 100 info@delsitech.com Sitemap TECHNOLOGY Silica drug delivery matrix Technology applications Benefits Patents Publications COMPANY PROFILE Business Strategy Board Management SERVICES Small molecule drug delivery Delivery solutions for biological macromolecus Virus vector delivery Manufacturing service Analytical service Why work with us PIPELINE Supergeneric drug developmet Business opportunities NEWS News archive CONTACT US Contact persons Contact form Careers VERKKOVARAANI